Exodus Point Capital Management, LP Ac Immune Sa Transaction History

Exodus Point Capital Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$6.04 - $8.37 $79,885 - $110,701	-13,226 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$5.32 - $8.96 $70,362 - $118,504	13,226 New	13,226 $101,000
Q4 2020 Feb 16, 2021	SELL	$4.47 - $5.58 $71,967 - $89,838	-16,100 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$4.78 - $9.06 $76,958 - $145,866	16,100 New	16,100 $79,000
Q1 2020 May 15, 2020	SELL	$4.24 - $9.89 $90,842 - $211,893	-21,425 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$4.56 - $8.78 $97,697 - $188,111	21,425 New	21,425 $183,000

28.6M

163K

37.6K

Ticker ACIU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,413,504
Market Cap $283M
Description
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.